Drug Profile
Iodine oral - Leo Pharma
Alternative Names: BPX 03; IoGenLatest Information Update: 20 Feb 2024
Price :
$50
*
At a glance
- Originator Symbollon Pharmaceuticals
- Developer Jacobson Resonance Enterprises; Symbollon Pharmaceuticals; Timber Pharmaceuticals
- Class Disinfectants; Halogens
- Mechanism of Action Apoptosis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Breast pain
- Discontinued Fibrocystic breast disorders; Solid tumours
Most Recent Events
- 23 Jan 2024 LEO Pharma acquires all assets from Timber Pharmaceuticals
- 18 May 2020 BioPharmX Corporation has been merged with Timber Pharmaceuticals to form Timber Pharmaceuticals
- 28 Nov 2018 No recent reports of development identified for clinical-Phase-Unknown development in Breast-pain in USA (PO, Tablet)